Overview

Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This Questionnaire

Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
validation of a french version of FACT-GOG/NTX and using this questionnaire to evaluate the incidence of the peripheral neurotoxicity in patients treated for ovarian cancer with paclitaxel associated or not with EPO.
Phase:
Phase 2
Details
Lead Sponsor:
ARCAGY/ GINECO GROUP
Treatments:
Albumin-Bound Paclitaxel
Paclitaxel